StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a report issued on Saturday. The brokerage set a “sell” rating on the stock.
SenesTech Stock Performance
Shares of NASDAQ SNES opened at $2.84 on Friday. SenesTech has a 52-week low of $1.90 and a 52-week high of $45.60. The company has a debt-to-equity ratio of 0.05, a quick ratio of 3.49 and a current ratio of 4.68. The firm has a 50 day moving average price of $2.71 and a 200 day moving average price of $4.78.
SenesTech (NASDAQ:SNES – Get Free Report) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($3.08) earnings per share for the quarter, topping analysts’ consensus estimates of ($3.20) by $0.12. SenesTech had a negative net margin of 464.09% and a negative return on equity of 168.64%. The company had revenue of $0.46 million for the quarter, compared to analysts’ expectations of $0.49 million. During the same period last year, the firm posted ($84.03) earnings per share. On average, sell-side analysts forecast that SenesTech will post -11 EPS for the current year.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- How to Find Undervalued Stocks
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- Profitably Trade Stocks at 52-Week Highs
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.